HSBC MSCI Europe UCITS ETF (EPA: HEU)
Assets | 202.08M |
Expense Ratio | 0.10% |
PE Ratio | 14.84 |
Dividend (ttm) | 0.50 |
Dividend Yield | 2.79% |
Ex-Dividend Date | n/a |
Payout Frequency | Semi-Annual |
Payout Ratio | n/a |
1-Year Return | +13.99% |
Volume | 722 |
Open | 17.78 |
Previous Close | 17.89 |
Day's Range | 17.78 - 17.93 |
52-Week Low | 14.77 |
52-Week High | 18.33 |
Beta | 0.99 |
Holdings | 461 |
Inception Date | Jun 1, 2010 |
About HEU
HSBC MSCI Europe UCITS ETF is an exchange traded fund launched and managed by HSBC Global Asset Management (UK) Limited. The fund invests in the public equity markets of developed countries in Europe. It seeks to invest in the stocks of companies operating across diversified sectors. The fund invests in the stocks of large-cap and mid-cap companies. It seeks to replicate the performance of the MSCI Europe Index, by investing in the stocks of companies as per their weightings in the index. The fund was formerly known as HSBC ETFs Public Limited Company - HSBC MSCI Europe ETF. HSBC MSCI Europe UCITS ETF was formed on June 1, 2010 and is domiciled in Ireland.
Performance
HEU had a total return of 13.99% in the past year. Since the fund's inception, the average annual return has been 7.84%, including dividends.
Top 10 Holdings
47.47% of assetsName | Symbol | Weight |
---|---|---|
Capital Cash Ctrl | n/a | 25.44% |
Novo Nordisk A/S | NOVO.B | 3.83% |
ASML Holding N.V. | ASML | 3.12% |
Nestle SA | NESN.SW | 2.46% |
AstraZeneca PLC | AZN | 2.32% |
Eur Capital Cash | n/a | 2.29% |
Novartis AG Registered Shares | NOVN.SW | 2.03% |
Roche Holding AG | ROG.SW | 2.03% |
SAP SE | SAP | 1.97% |
Shell plc | SHEL | 1.96% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Aug 8, 2024 | €0.3852 | Aug 30, 2024 |
Feb 1, 2024 | €0.114 | Feb 22, 2024 |
Aug 3, 2023 | €0.348 | Aug 25, 2023 |
Feb 2, 2023 | €0.1141 | Feb 24, 2023 |
Jul 28, 2022 | €0.3221 | Aug 19, 2022 |
Jan 27, 2022 | €0.1212 | Feb 18, 2022 |